Global and United States Antiretroviral Therapy Market Insights, Forecast to 2026

Global and United States Antiretroviral Therapy Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Antiretroviral Therapy Product Introduction
1.2 Market Segments
1.3 Key Antiretroviral Therapy Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Antiretroviral Therapy Market Size Growth Rate by Type
1.4.2 NNRTIs
1.4.3 NRTI
1.4.4 Multiclass Combination Products
1.4.5 Integrase Inhibitors
1.5 Market by Application
1.5.1 Global Antiretroviral Therapy Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Antiretroviral Therapy Market Size, Estimates and Forecasts
2.1.1 Global Antiretroviral Therapy Revenue 2015-2026
2.1.2 Global Antiretroviral Therapy Sales 2015-2026
2.2 Global Antiretroviral Therapy, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Antiretroviral Therapy Historical Market Size by Region (2015-2020)
2.3.1 Global Antiretroviral Therapy Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Antiretroviral Therapy Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Antiretroviral Therapy Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Antiretroviral Therapy Sales Forecast by Region (2021-2026)
2.4.2 Global Antiretroviral Therapy Revenue Forecast by Region (2021-2026)
3 Global Antiretroviral Therapy Competitor Landscape by Players
3.1 Global Top Antiretroviral Therapy Sales by Manufacturers
3.1.1 Global Antiretroviral Therapy Sales by Manufacturers (2015-2020)
3.1.2 Global Antiretroviral Therapy Sales Market Share by Manufacturers (2015-2020)
3.2 Global Antiretroviral Therapy Manufacturers by Revenue
3.2.1 Global Antiretroviral Therapy Revenue by Manufacturers (2015-2020)
3.2.2 Global Antiretroviral Therapy Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Antiretroviral Therapy Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Antiretroviral Therapy Revenue in 2019
3.2.5 Global Antiretroviral Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Antiretroviral Therapy Price by Manufacturers
3.4 Global Antiretroviral Therapy Manufacturing Base Distribution, Product Types
3.4.1 Antiretroviral Therapy Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Antiretroviral Therapy Product Type
3.4.3 Date of International Manufacturers Enter into Antiretroviral Therapy Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Antiretroviral Therapy Market Size by Type (2015-2020)
4.1.1 Global Antiretroviral Therapy Sales by Type (2015-2020)
4.1.2 Global Antiretroviral Therapy Revenue by Type (2015-2020)
4.1.3 Antiretroviral Therapy Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Antiretroviral Therapy Market Size Forecast by Type (2021-2026)
4.2.1 Global Antiretroviral Therapy Sales Forecast by Type (2021-2026)
4.2.2 Global Antiretroviral Therapy Revenue Forecast by Type (2021-2026)
4.2.3 Antiretroviral Therapy Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Antiretroviral Therapy Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Antiretroviral Therapy Market Size by Application (2015-2020)
5.1.1 Global Antiretroviral Therapy Sales by Application (2015-2020)
5.1.2 Global Antiretroviral Therapy Revenue by Application (2015-2020)
5.1.3 Antiretroviral Therapy Price by Application (2015-2020)
5.2 Antiretroviral Therapy Market Size Forecast by Application (2021-2026)
5.2.1 Global Antiretroviral Therapy Sales Forecast by Application (2021-2026)
5.2.2 Global Antiretroviral Therapy Revenue Forecast by Application (2021-2026)
5.2.3 Global Antiretroviral Therapy Price Forecast by Application (2021-2026)
6 United States by Players, Type and Application
6.1 United States Antiretroviral Therapy Market Size YoY Growth 2015-2026
6.1.1 United States Antiretroviral Therapy Sales YoY Growth 2015-2026
6.1.2 United States Antiretroviral Therapy Revenue YoY Growth 2015-2026
6.1.3 United States Antiretroviral Therapy Market Share in Global Market 2015-2026
6.2 United States Antiretroviral Therapy Market Size by Players (International and Local Players)
6.2.1 United States Top Antiretroviral Therapy Players by Sales (2015-2020)
6.2.2 United States Top Antiretroviral Therapy Players by Revenue (2015-2020)
6.3 United States Antiretroviral Therapy Historic Market Review by Type (2015-2020)
6.3.1 United States Antiretroviral Therapy Sales Market Share by Type (2015-2020)
6.3.2 United States Antiretroviral Therapy Revenue Market Share by Type (2015-2020)
6.3.3 United States Antiretroviral Therapy Price by Type (2015-2020)
6.4 United States Antiretroviral Therapy Market Estimates and Forecasts by Type (2021-2026)
6.4.1 United States Antiretroviral Therapy Sales Forecast by Type (2021-2026)
6.4.2 United States Antiretroviral Therapy Revenue Forecast by Type (2021-2026)
6.4.3 United States Antiretroviral Therapy Price Forecast by Type (2021-2026)
6.5 United States Antiretroviral Therapy Historic Market Review by Application (2015-2020)
6.5.1 United States Antiretroviral Therapy Sales Market Share by Application (2015-2020)
6.5.2 United States Antiretroviral Therapy Revenue Market Share by Application (2015-2020)
6.5.3 United States Antiretroviral Therapy Price by Application (2015-2020)
6.6 United States Antiretroviral Therapy Market Estimates and Forecasts by Application (2021-2026)
6.6.1 United States Antiretroviral Therapy Sales Forecast by Application (2021-2026)
6.6.2 United States Antiretroviral Therapy Revenue Forecast by Application (2021-2026)
6.6.3 United States Antiretroviral Therapy Price Forecast by Application (2021-2026)
7 North America
7.1 North America Antiretroviral Therapy Market Size YoY Growth 2015-2026
7.2 North America Antiretroviral Therapy Market Facts & Figures by Country
7.2.1 North America Antiretroviral Therapy Sales by Country (2015-2020)
7.2.2 North America Antiretroviral Therapy Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Antiretroviral Therapy Market Size YoY Growth 2015-2026
8.2 Europe Antiretroviral Therapy Market Facts & Figures by Country
8.2.1 Europe Antiretroviral Therapy Sales by Country
8.2.2 Europe Antiretroviral Therapy Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Antiretroviral Therapy Market Size YoY Growth 2015-2026
9.2 Asia Pacific Antiretroviral Therapy Market Facts & Figures by Country
9.2.1 Asia Pacific Antiretroviral Therapy Sales by Region (2015-2020)
9.2.2 Asia Pacific Antiretroviral Therapy Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Antiretroviral Therapy Market Size YoY Growth 2015-2026
10.2 Latin America Antiretroviral Therapy Market Facts & Figures by Country
10.2.1 Latin America Antiretroviral Therapy Sales by Country
10.2.2 Latin America Antiretroviral Therapy Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Antiretroviral Therapy Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Antiretroviral Therapy Market Facts & Figures by Country
11.2.1 Middle East and Africa Antiretroviral Therapy Sales by Country
11.2.2 Middle East and Africa Antiretroviral Therapy Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Gilead
12.1.1 Gilead Corporation Information
12.1.2 Gilead Description and Business Overview
12.1.3 Gilead Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Gilead Antiretroviral Therapy Products Offered
12.1.5 Gilead Recent Development
12.2 F. Hoffmann-La Roche
12.2.1 F. Hoffmann-La Roche Corporation Information
12.2.2 F. Hoffmann-La Roche Description and Business Overview
12.2.3 F. Hoffmann-La Roche Sales, Revenue and Gross Margin (2015-2020)
12.2.4 F. Hoffmann-La Roche Antiretroviral Therapy Products Offered
12.2.5 F. Hoffmann-La Roche Recent Development
12.3 ViiV Healthcare
12.3.1 ViiV Healthcare Corporation Information
12.3.2 ViiV Healthcare Description and Business Overview
12.3.3 ViiV Healthcare Sales, Revenue and Gross Margin (2015-2020)
12.3.4 ViiV Healthcare Antiretroviral Therapy Products Offered
12.3.5 ViiV Healthcare Recent Development
12.4 Boehringer Ingelheim
12.4.1 Boehringer Ingelheim Corporation Information
12.4.2 Boehringer Ingelheim Description and Business Overview
12.4.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Boehringer Ingelheim Antiretroviral Therapy Products Offered
12.4.5 Boehringer Ingelheim Recent Development
12.5 Janssen Pharmaceuticals
12.5.1 Janssen Pharmaceuticals Corporation Information
12.5.2 Janssen Pharmaceuticals Description and Business Overview
12.5.3 Janssen Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Janssen Pharmaceuticals Antiretroviral Therapy Products Offered
12.5.5 Janssen Pharmaceuticals Recent Development
12.6 Mylan
12.6.1 Mylan Corporation Information
12.6.2 Mylan Description and Business Overview
12.6.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Mylan Antiretroviral Therapy Products Offered
12.6.5 Mylan Recent Development
12.7 Abbvie
12.7.1 Abbvie Corporation Information
12.7.2 Abbvie Description and Business Overview
12.7.3 Abbvie Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Abbvie Antiretroviral Therapy Products Offered
12.7.5 Abbvie Recent Development
12.8 Bionor Pharma
12.8.1 Bionor Pharma Corporation Information
12.8.2 Bionor Pharma Description and Business Overview
12.8.3 Bionor Pharma Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Bionor Pharma Antiretroviral Therapy Products Offered
12.8.5 Bionor Pharma Recent Development
12.9 Vertex Pharmaceuticals
12.9.1 Vertex Pharmaceuticals Corporation Information
12.9.2 Vertex Pharmaceuticals Description and Business Overview
12.9.3 Vertex Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Vertex Pharmaceuticals Antiretroviral Therapy Products Offered
12.9.5 Vertex Pharmaceuticals Recent Development
12.11 Gilead
12.11.1 Gilead Corporation Information
12.11.2 Gilead Description and Business Overview
12.11.3 Gilead Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Gilead Antiretroviral Therapy Products Offered
12.11.5 Gilead Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Antiretroviral Therapy Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Antiretroviral Therapy Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Antiretroviral Therapy Market Segments
Table 2. Ranking of Global Top Antiretroviral Therapy Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Antiretroviral Therapy Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of NNRTIs
Table 5. Major Manufacturers of NRTI
Table 6. Major Manufacturers of Multiclass Combination Products
Table 7. Major Manufacturers of Integrase Inhibitors
Table 8. Global Antiretroviral Therapy Market Size Growth Rate by Application 2020-2026 (K MT)
Table 9. Global Antiretroviral Therapy Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 10. Global Antiretroviral Therapy Sales by Regions 2015-2020 (K MT)
Table 11. Global Antiretroviral Therapy Sales Market Share by Regions (2015-2020)
Table 12. Global Antiretroviral Therapy Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global Antiretroviral Therapy Sales Forecast by Region (2021-2026) (K MT)
Table 14. Global Antiretroviral Therapy Sales by Manufacturers (2015-2020) (K MT)
Table 15. Global Antiretroviral Therapy Sales Share by Manufacturers (2015-2020)
Table 16. Global Antiretroviral Therapy Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Antiretroviral Therapy by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antiretroviral Therapy as of 2019)
Table 18. Antiretroviral Therapy Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Antiretroviral Therapy Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Antiretroviral Therapy Price (2015-2020) (USD/MT)
Table 21. Antiretroviral Therapy Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Antiretroviral Therapy Product Type
Table 23. Date of International Manufacturers Enter into Antiretroviral Therapy Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Antiretroviral Therapy Sales by Type (2015-2020) (K MT)
Table 26. Global Antiretroviral Therapy Sales Share by Type (2015-2020)
Table 27. Global Antiretroviral Therapy Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Antiretroviral Therapy Revenue Share by Type (2015-2020)
Table 29. Antiretroviral Therapy Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 30. Global Antiretroviral Therapy Sales Share by Type (2021-2026)
Table 31. Global Antiretroviral Therapy Sales by Application (2015-2020) (K MT)
Table 32. Global Antiretroviral Therapy Sales Share by Application (2015-2020)
Table 33. Global Antiretroviral Therapy Sales Share by Application (2021-2026)
Table 34. Global Antiretroviral Therapy Sales Market Share Forecast by Application (2021-2026)
Table 35. Global Antiretroviral Therapy Revenue by Application (2015-2020) (US$ Million)
Table 36. Global Antiretroviral Therapy Revenue Market Share Forecast by Application (2021-2026)
Table 37. United States Antiretroviral Therapy Sales (K MT) of Key Companies (2015-2020)
Table 38. United States Antiretroviral Therapy Sales Share by Company (2015-2020)
Table 39. United States Antiretroviral Therapy Revenue (US$ Million) by Company (2015-2020)
Table 40. United States Antiretroviral Therapy Sales (K MT) by Type (2015-2020)
Table 41. United States Antiretroviral Therapy Sales Share by Type (2015-2020)
Table 42. United States Antiretroviral Therapy Revenue (US$ Million) Market Share by Type (2015-2020)
Table 43. United States Antiretroviral Therapy Price (K MT) by Type (2015-2020)
Table 44. United States Antiretroviral Therapy Sales (K MT) by Type (2021-2026)
Table 45. United States Antiretroviral Therapy Sales Share by Type (2021-2026)
Table 46. United States Antiretroviral Therapy Revenue (US$ Million) Market Share by Type (2021-2026)
Table 47. United States Antiretroviral Therapy Revenue Share by Type (2021-2026)
Table 48. United States Antiretroviral Therapy Price (K MT) by Type (2021-2026)
Table 49. United States Antiretroviral Therapy Sales (K MT) by Application (2015-2020)
Table 50. United States Antiretroviral Therapy Sales Share by Application (2015-2020)
Table 51. United States Antiretroviral Therapy Revenue (US$ Million) Market Share by Application (2015-2020)
Table 52. United States Antiretroviral Therapy Sales (K MT) by Application (2021-2026)
Table 53. United States Antiretroviral Therapy Sales Share by Application (2021-2026)
Table 54. United States Antiretroviral Therapy Revenue (US$ Million) Market Share by Application (2021-2026)
Table 55. United States Antiretroviral Therapy Revenue Share by Application (2021-2026)
Table 56. North America Antiretroviral Therapy Sales by Country (2015-2020) (K MT)
Table 57. North America Antiretroviral Therapy Sales Market Share by Country (2015-2020)
Table 58. North America Antiretroviral Therapy Revenue by Country (2015-2020) (US$ Million)
Table 59. North America Antiretroviral Therapy Revenue Market Share by Country (2015-2020)
Table 60. Europe Antiretroviral Therapy Sales by Country (2015-2020) (K MT)
Table 61. Europe Antiretroviral Therapy Sales Market Share by Country (2015-2020)
Table 62. Europe Antiretroviral Therapy Revenue by Country (2015-2020) (US$ Million)
Table 63. Europe Antiretroviral Therapy Revenue Market Share by Country (2015-2020)
Table 64. Asia Pacific Antiretroviral Therapy Sales by Region (2015-2020) (K MT)
Table 65. Asia Pacific Antiretroviral Therapy Sales Market Share by Region (2015-2020)
Table 66. Asia Pacific Antiretroviral Therapy Revenue by Region (2015-2020) (US$ Million)
Table 67. Asia Pacific Antiretroviral Therapy Revenue Market Share by Region (2015-2020)
Table 68. Latin America Antiretroviral Therapy Sales by Country (2015-2020) (K MT)
Table 69. Latin America Antiretroviral Therapy Sales Market Share by Country (2015-2020)
Table 70. Latin Americaa Antiretroviral Therapy Revenue by Country (2015-2020) (US$ Million)
Table 71. Latin America Antiretroviral Therapy Revenue Market Share by Country (2015-2020)
Table 72. Middle East and Africa Antiretroviral Therapy Sales by Country (2015-2020) (K MT)
Table 73. Middle East and Africa Antiretroviral Therapy Sales Market Share by Country (2015-2020)
Table 74. Middle East and Africa Antiretroviral Therapy Revenue by Country (2015-2020) (US$ Million)
Table 75. Middle East and Africa Antiretroviral Therapy Revenue Market Share by Country (2015-2020)
Table 76. Gilead Corporation Information
Table 77. Gilead Description and Business Overview
Table 78. Gilead Antiretroviral Therapy Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 79. Gilead Antiretroviral Therapy Product
Table 80. Gilead Recent Development
Table 81. F. Hoffmann-La Roche Corporation Information
Table 82. F. Hoffmann-La Roche Description and Business Overview
Table 83. F. Hoffmann-La Roche Antiretroviral Therapy Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 84. F. Hoffmann-La Roche Product
Table 85. F. Hoffmann-La Roche Recent Development
Table 86. ViiV Healthcare Corporation Information
Table 87. ViiV Healthcare Description and Business Overview
Table 88. ViiV Healthcare Antiretroviral Therapy Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 89. ViiV Healthcare Product
Table 90. ViiV Healthcare Recent Development
Table 91. Boehringer Ingelheim Corporation Information
Table 92. Boehringer Ingelheim Description and Business Overview
Table 93. Boehringer Ingelheim Antiretroviral Therapy Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 94. Boehringer Ingelheim Product
Table 95. Boehringer Ingelheim Recent Development
Table 96. Janssen Pharmaceuticals Corporation Information
Table 97. Janssen Pharmaceuticals Description and Business Overview
Table 98. Janssen Pharmaceuticals Antiretroviral Therapy Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 99. Janssen Pharmaceuticals Product
Table 100. Janssen Pharmaceuticals Recent Development
Table 101. Mylan Corporation Information
Table 102. Mylan Description and Business Overview
Table 103. Mylan Antiretroviral Therapy Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 104. Mylan Product
Table 105. Mylan Recent Development
Table 106. Abbvie Corporation Information
Table 107. Abbvie Description and Business Overview
Table 108. Abbvie Antiretroviral Therapy Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 109. Abbvie Product
Table 110. Abbvie Recent Development
Table 111. Bionor Pharma Corporation Information
Table 112. Bionor Pharma Description and Business Overview
Table 113. Bionor Pharma Antiretroviral Therapy Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 114. Bionor Pharma Product
Table 115. Bionor Pharma Recent Development
Table 116. Vertex Pharmaceuticals Corporation Information
Table 117. Vertex Pharmaceuticals Description and Business Overview
Table 118. Vertex Pharmaceuticals Antiretroviral Therapy Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 119. Vertex Pharmaceuticals Product
Table 120. Vertex Pharmaceuticals Recent Development
Table 121. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 122. Key Challenges
Table 123. Market Risks
Table 124. Main Points Interviewed from Key Antiretroviral Therapy Players
Table 125. Antiretroviral Therapy Customers List
Table 126. Antiretroviral Therapy Distributors List
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Antiretroviral Therapy Product Picture
Figure 2. Global Antiretroviral Therapy Sales Market Share by Type in 2020 & 2026
Figure 3. NNRTIs Product Picture
Figure 4. NRTI Product Picture
Figure 5. Multiclass Combination Products Product Picture
Figure 6. Integrase Inhibitors Product Picture
Figure 7. Global Antiretroviral Therapy Sales Market Share by Application in 2020 & 2026
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Other
Figure 11. Antiretroviral Therapy Report Years Considered
Figure 12. Global Antiretroviral Therapy Market Size 2015-2026 (US$ Million)
Figure 13. Global Antiretroviral Therapy Sales 2015-2026 (K MT)
Figure 14. Global Antiretroviral Therapy Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Antiretroviral Therapy Sales Market Share by Region (2015-2020)
Figure 16. Global Antiretroviral Therapy Sales Market Share by Region in 2019
Figure 17. Global Antiretroviral Therapy Revenue Market Share by Region (2015-2020)
Figure 18. Global Antiretroviral Therapy Revenue Market Share by Region in 2019
Figure 19. Global Antiretroviral Therapy Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Antiretroviral Therapy Revenue in 2019
Figure 21. Antiretroviral Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Antiretroviral Therapy Sales Market Share by Type (2015-2020)
Figure 23. Global Antiretroviral Therapy Sales Market Share by Type in 2019
Figure 24. Global Antiretroviral Therapy Revenue Market Share by Type (2015-2020)
Figure 25. Global Antiretroviral Therapy Revenue Market Share by Type in 2019
Figure 26. Global Antiretroviral Therapy Market Share by Price Range (2015-2020)
Figure 27. Global Antiretroviral Therapy Sales Market Share by Application (2015-2020)
Figure 28. Global Antiretroviral Therapy Sales Market Share by Application in 2019
Figure 29. Global Antiretroviral Therapy Revenue Market Share by Application (2015-2020)
Figure 30. Global Antiretroviral Therapy Revenue Market Share by Application in 2019
Figure 31. United States Antiretroviral Therapy Sales Growth Rate 2015-2026 (K MT)
Figure 32. United States Antiretroviral Therapy Revenue Growth Rate 2015-2026 (US$ Million)
Figure 33. United States Antiretroviral Therapy Market Share in Global Market 2015-2026
Figure 34. United States 5 and 10 Largest Antiretroviral Therapy Players Market Share by Revenue in Antiretroviral Therapy in 2019
Figure 35. United States Antiretroviral Therapy Revenue Share by Type (2015-2020)
Figure 36. United States Antiretroviral Therapy Revenue Growth Rate by Type in 2015 & 2019
Figure 37. United States Antiretroviral Therapy Revenue Share by Application (2015-2020)
Figure 38. United States Antiretroviral Therapy Revenue Growth Rate by Application in 2015 & 2019
Figure 39. North America Antiretroviral Therapy Sales Growth Rate 2015-2020 (K MT)
Figure 40. North America Antiretroviral Therapy Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. North America Antiretroviral Therapy Sales Market Share by Country in 2019
Figure 42. North America Antiretroviral Therapy Revenue Market Share by Country in 2019
Figure 43. U.S. Antiretroviral Therapy Sales Growth Rate (2015-2020) (K MT)
Figure 44. U.S. Antiretroviral Therapy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. Canada Antiretroviral Therapy Sales Growth Rate (2015-2020) (K MT)
Figure 46. Canada Antiretroviral Therapy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. Europe Antiretroviral Therapy Sales Growth Rate 2015-2020 (K MT)
Figure 48. Europe Antiretroviral Therapy Revenue Growth Rate 2015-2020 (US$ Million)
Figure 49. Europe Antiretroviral Therapy Sales Market Share by Country in 2019
Figure 50. Europe Antiretroviral Therapy Revenue Market Share by Country in 2019
Figure 51. Germany Antiretroviral Therapy Sales Growth Rate (2015-2020) (K MT)
Figure 52. Germany Antiretroviral Therapy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. France Antiretroviral Therapy Sales Growth Rate (2015-2020) (K MT)
Figure 54. France Antiretroviral Therapy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. U.K. Antiretroviral Therapy Sales Growth Rate (2015-2020) (K MT)
Figure 56. U.K. Antiretroviral Therapy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Italy Antiretroviral Therapy Sales Growth Rate (2015-2020) (K MT)
Figure 58. Italy Antiretroviral Therapy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Russia Antiretroviral Therapy Sales Growth Rate (2015-2020) (K MT)
Figure 60. Russia Antiretroviral Therapy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Asia Pacific Antiretroviral Therapy Sales Growth Rate 2015-2020 (K MT)
Figure 62. Asia Pacific Antiretroviral Therapy Revenue Growth Rate 2015-2020 (US$ Million)
Figure 63. Asia Pacific Antiretroviral Therapy Sales Market Share by Region in 2019
Figure 64. Asia Pacific Antiretroviral Therapy Revenue Market Share by Region in 2019
Figure 65. China Antiretroviral Therapy Sales Growth Rate (2015-2020) (K MT)
Figure 66. China Antiretroviral Therapy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Japan Antiretroviral Therapy Sales Growth Rate (2015-2020) (K MT)
Figure 68. Japan Antiretroviral Therapy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. South Korea Antiretroviral Therapy Sales Growth Rate (2015-2020) (K MT)
Figure 70. South Korea Antiretroviral Therapy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. India Antiretroviral Therapy Sales Growth Rate (2015-2020) (K MT)
Figure 72. India Antiretroviral Therapy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Australia Antiretroviral Therapy Sales Growth Rate (2015-2020) (K MT)
Figure 74. Australia Antiretroviral Therapy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Taiwan Antiretroviral Therapy Sales Growth Rate (2015-2020) (K MT)
Figure 76. Taiwan Antiretroviral Therapy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Indonesia Antiretroviral Therapy Sales Growth Rate (2015-2020) (K MT)
Figure 78. Indonesia Antiretroviral Therapy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Thailand Antiretroviral Therapy Sales Growth Rate (2015-2020) (K MT)
Figure 80. Thailand Antiretroviral Therapy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Malaysia Antiretroviral Therapy Sales Growth Rate (2015-2020) (K MT)
Figure 82. Malaysia Antiretroviral Therapy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Philippines Antiretroviral Therapy Sales Growth Rate (2015-2020) (K MT)
Figure 84. Philippines Antiretroviral Therapy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Vietnam Antiretroviral Therapy Sales Growth Rate (2015-2020) (K MT)
Figure 86. Vietnam Antiretroviral Therapy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 87. Latin America Antiretroviral Therapy Sales Growth Rate 2015-2020 (K MT)
Figure 88. Latin America Antiretroviral Therapy Revenue Growth Rate 2015-2020 (US$ Million)
Figure 89. Latin America Antiretroviral Therapy Sales Market Share by Country in 2019
Figure 90. Latin America Antiretroviral Therapy Revenue Market Share by Country in 2019
Figure 91. Mexico Antiretroviral Therapy Sales Growth Rate (2015-2020) (K MT)
Figure 92. Mexico Antiretroviral Therapy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Brazil Antiretroviral Therapy Sales Growth Rate (2015-2020) (K MT)
Figure 94. Brazil Antiretroviral Therapy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Argentina Antiretroviral Therapy Sales Growth Rate (2015-2020) (K MT)
Figure 96. Argentina Antiretroviral Therapy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Middle East and Africa Antiretroviral Therapy Sales Growth Rate 2015-2020 (K MT)
Figure 98. Middle East and Africa Antiretroviral Therapy Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Antiretroviral Therapy Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Antiretroviral Therapy Revenue Market Share by Country in 2019
Figure 101. Turkey Antiretroviral Therapy Sales Growth Rate (2015-2020) (K MT)
Figure 102. Turkey Antiretroviral Therapy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Antiretroviral Therapy Sales Growth Rate (2015-2020) (K MT)
Figure 104. Saudi Arabia Antiretroviral Therapy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Antiretroviral Therapy Sales Growth Rate (2015-2020) (K MT)
Figure 106. U.A.E Antiretroviral Therapy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Porter's Five Forces Analysis
Figure 108. Antiretroviral Therapy Value Chain
Figure 109. Channels of Distribution
Figure 110. Distributors Profiles
Figure 111. Bottom-up and Top-down Approaches for This Report
Figure 112. Data Triangulation
Figure 113. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antiretroviral Therapy Market Research Report 2023

Published: 14-Dec-2023        Price: US 2900 Onwards        Pages: 86

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Antiretroviral Therapy market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Gilead - F. Hoffmann-La Roche - ViiV Healthcare - Boehringer Ingelheim - Janssen Pharmaceuticals - Mylan - Abbvie - Bionor Pharma......

Global Antiretroviral Therapy Professional Survey Report 2023, Forecast to 2028

Published: 22-Mar-2023        Price: US 3280 Onwards        Pages: 108

Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......

Global Antiretroviral Therapy Market Research Report 2023, Forecast to 2028

Published: 22-Mar-2023        Price: US 2680 Onwards        Pages: 131

Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......

Global Antiretroviral Therapy Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Published: 21-Sep-2022        Price: US 5600 Onwards        Pages: 104

Report Scope This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers' production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Antiretroviral Therapy manufacturers, distributors, end users, industry associations, governments' industry bureaus, indust......

Global Antiretroviral Therapy Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Published: 31-Jul-2022        Price: US 3480 Onwards        Pages: 96

The Antiretroviral Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations. According to our (Global I......

Global Antiretroviral Therapy Market Insights and Forecast to 2028

Published: 07-Apr-2022        Price: US 4900 Onwards        Pages: 89

Antiretroviral Therapy market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Antiretroviral Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type - NNRTIs - NRTI - Multiclass Combination Products - Integrase Inhibitors ......

United States Antiretroviral Therapy Market Report & Forecast 2021-2027

Published: 25-Nov-2021        Price: US 3400 Onwards        Pages: 93

United States Antiretroviral Therapy Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (KG) United States Antiretroviral Therapy Market Segment Percentages, By Type, 2020 (%) - NNRTIs - NRTI - Multiclass Combination Products - Integrase Inhibitors United States Antiretroviral Therapy Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (KG) United States Antiretroviral Therapy Market Segment Percentages, By Application, 2020 (%)......

China Antiretroviral Therapy Market Report & Forecast 2021-2027

Published: 03-Nov-2021        Price: US 3400 Onwards        Pages: 91

China Antiretroviral Therapy Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (KG) China Antiretroviral Therapy Market Segment Percentages, By Type, 2020 (%) - NNRTIs - NRTI - Multiclass Combination Products - Integrase Inhibitors China Antiretroviral Therapy Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (KG) China Antiretroviral Therapy Market Segment Percentages, By Application, 2020 (%) - Hospital - Clini......

Global and United States Antiretroviral Therapy Market Insights, Forecast to 2027

Published: 12-Aug-2021        Price: US 3900 Onwards        Pages: 130

Antiretroviral Therapy market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Antiretroviral Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For United States market, this report focuses on the Ant......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs